Neurogenic (autonomic) factors in hypertensive vascular disease (1, 2) may be studied with hexamethonium 2 which reduces arterial blood pressure by blockade of the sympathetic ganglia. When the blood pressure is reduced acutely in this manner, alterations in renal hemodynamics have been observed. Following a single dose of hexamethonium administered parenterally to patients with hypertension, the glomerular filtration rate and renal plasma flow are immediately depressed but within one hour renal hemodynamic readjustment occurs and both functions return to or towards control values, although the arterial blood pressure remains depressed (3, 4) for two to six hours. The present study was designed to evaluate the effects of prolonged reduction of blood pressure in hypertensive patients, with and without renal damage, during the therapeutic oral administration of hexamethonium. In addition to studies in the supine position, observations on renal hemodynamics were made during ambulation before and during therapy. The latter observations were made in order to evaluate the effect of ganglionic blockade on the renal vasoconstriction which normally is associated with changing from the supine to the upright position (either static tilt or ambulation) in the untreated patient (5).
Neurogenic (autonomic) factors in hypertensive vascular disease (1, 2) may be studied with hexamethonium 2 which reduces arterial blood pressure by blockade of the sympathetic ganglia. When the blood pressure is reduced acutely in this manner, alterations in renal hemodynamics have been observed. Following a single dose of hexamethonium administered parenterally to patients with hypertension, the glomerular filtration rate and renal plasma flow are immediately depressed but within one hour renal hemodynamic readjustment occurs and both functions return to or towards control values, although the arterial blood pressure remains depressed (3, 4) for two to six hours. The present study was designed to evaluate the effects of prolonged reduction of blood pressure in hypertensive patients, with and without renal damage, during the therapeutic oral administration of hexamethonium. In addition to studies in the supine position, observations on renal hemodynamics were made during ambulation before and during therapy. The latter observations were made in order to evaluate the effect of ganglionic blockade on the renal vasoconstriction which normally is associated with changing from the supine to the upright position (either static tilt or ambulation) in the untreated patient (5) .
METHODS
Seven patients with hypertension were studied by measurements of glomerular filtration rate (inulin clearance), renal plasma flow (para-aminohippurate clearance), and maximum tubular excretory capacity (TmPAH). The rates of urine formation, sodium excretion, potassium excretion, and the changes in blood pressure were observed. 1 Supported in part by a grant from the National Institutes of Health, United States Public Health Service. 2 Supplied through the courtesy of Burroughs Wellcome and Company and Ciba Pharmaceutical Products, Inc.
The techniques of renal function and the methods of analysis have been previously described (3). The control determinations of glomerular filtration rate (GFR) and renal plasma flow (RPF) consisted of three consecutive 10-minute periods in recumbency, followed by three periods in the ambulatory state. During the ambulatory studies the patients pushed the equipment mounted on a small table equipped with wheels. Following these six periods and after a 60-minute equilibration and rest period in the recumbent position, three control determinations of GFR and TmPAH were performed. These were followed by three periods in the ambulatory state. The patients were then given hexamethonium orally four times daily to establish a reduction in mean blood pressure of 40 mm. Hg or more when in the upright position. The second group of studies ("drug" studies) were done after one month or more and after at least seven days of consistent reduction of blood pressure. The renal function studies were then repeated in precisely the same fashion as the control studies, recumbent and ambulatory. Supine studies on GFR and RPF were done on an additional six patients (XM to XCa, Tables I and II) who were treated in a similar fashion. Determination of TmPAH was done on one patient in this latter group. Blood pressures were determined on the first seven patients with a sphygmomanometer and on the last six patients by intra-arterial manometry.
Observations on the effect of ambulation on electrolyte excretion were made on one additional patient (Table IV) who received hexamethonium as oral therapy for hypertension and who had an adequate response in blood pressure reduction in the upright position. He was studied in the metabolic ward and was given a constant diet in terms of calories (2,300), protein (70 Gm.), sodium (800 mg. NaCI), potassium (700 mg.), chloride (800 mg. NaCI), and water (3,000 ml.). After a five-day equilibration period, the urine was collected in four-hour periods for three consecutive days. It was analyzed for chloride, sodium, and potassium. The patient was ambulatory for three periods and recumbent for three periods during each day.
RESULTS
The patients required an average oral dose of 875 mg. of hexamethonium every six hours in or-der to obtain a consistent lowering of blood pressure. The percentile reduction in systolic pressure was equal to the percentile reduction in diastolic pressure. A typical study is summarized in Figure 1 When the RBF in the supine position after hexamethonium is used as the reference point, the response to ambulation represents an even greater reduction (Table II) . Ambulation after hexamethonium caused an average increase in RVR to only 105 per cent of the control, supine value.
However, the percentage increase following ambulation is considerably greater when the post-drug supine value is used as the reference point.
III. Effect of oral hexamethonium on water and electrolyte excretion Prior to hexamethonium administration, ambulation caused a reduction in urine volume and sodium excretion to 79 per cent and 75 per cent of the control supine observations, respectively, without a reduction in blood pressure. After ganglionic blockade and blood pressure reduction with hexamethonium, ambulation produced a further decrease in blood pressure by comparison to the supine post-drug value. This was associated with a sharp reduction in urine volume and in sodium excretion. The changes brought about by ambulation were of a somewhat greater magnitude (percentagewise) than those observed following ambu- lation during the control period. There was no yet, after one month of therapy, all but one of the change in potassium excretion due to ambulation patients showed a reduction in plasma sodium con-(106 per cent of supine control) during the con-centration. The lone exception was the only patrol period but after hexamethonium there was an tient who did not show a decrease in the excretion apparent decrease to 79 per cent of the supine of sodium in the post-drug supine state as comvalue during hexamethonium therapy. pared to the control supine value. Despite the apThe patients were given a constant sodium diet parent decrease in sodium and water excretion durfor two weeks prior to receiving hexamethonium ing the studies which were performed after receivand throughout the period of drug administration; ing hexamethonium for one month, none of the pa- The participation of neurogenic reflexes in the control of renal functions is suggested by the changes accompanying tilting (5) or ambulation as summarized in Table V (CA/CR) . Renal vasoconstriction occurs as evidenced by the increase in RVR and a decrease in GFR, RBF, and TmPAH, but minimal, if any, change in blood pressure. This is associated with a decrease in the excretion of water and sodium. During hexamethonium therapy, there is an additional reduction in blood pressure due to ambulation which is also accompanied by a reduction in GFR, RBF, TmPAH, and the excretion of water, sodium, and potassium (Table V, DA/DR). There is very little increase in RVR in the ambulatory state after hexamethonium as compared to the recumbent state before the drug is administered (DA/DR). However, when the recumbent state after ganglionic blockade is used as the baseline there is nearly as great a percentile increase in RVR due to ambulation as there was in the untreated patient (Table V , DA/DR as compared to CA/CR, respectively). This indicates that under the stress of postural changes, reflex vasoconstrictive mechanisms in the kidney are retained despite partial ganglionic blockade with hexamethonium. In spite of the (apparent) depression of renal hemodynamics during ambulation there was no instance of increased renal decompensation as manifested by a rising blood urea nitrogen.
The explanation for the depression of water and electrolyte excretion during hexamethonium therapy is not apparent. Even during recumbency, the present data show a decrease in water and sodium excretion during hexamethonium therapy as compared to the control observations. The reduction in plasma sodium concentration suggests a partial depletion of this electrolyte during the administration of hexamethonium. A depleted state due to sodium loss during the initial administration of hexamethonium might be reflected in decreased excretion of sodium in the urine after receiving hexamethonium for prolonged periods (one month or more). The initial response to hexamethonium administration was not studied since this observation on sodium excretion was not anticipated. Variations in sodium and water intake between the control study and one month later may also be responsible for the reduced sodium excretion since sodium intake was not rigidly controlled in these patients.
The amount of sodium in the diet was kept constant during the study and for a two-week control period before the drug was administered. However, one cannot be sure that the patients consumed their entire diet. This may well be a factor since initial therapy with hexamethonium is frequently associated with a decreased appetite. Before any conclusions are drawn in this regard the problem should be investigated in more detail and the observations confirmed by other investigators.
The acute response to ambulation may well be a neurogenic response, since neurogenic impulses to the kidney may cause an increase in tubular reabsorption of water and sodium. There is evidence to indicate that it is not of hormonal origin since Murphy and Stead (7) have shown that endogenous antidiuretic hormone does not increase sodium reabsorption in man. In spite of the apparent depression of excretion of water and electrolytes, none of the patients exhibited edema or other signs of fluid retention. In one patient studied by observations of excretion rates of water, sodium, potassium, and chloride during four-hour periods at which time he was either ambulatory or recumbent, there was a decrease in excretion during ambulation but an increase during recumbency. During the sleeping hours, excretion of sodium and water during the first (11 to 3 a.m.) recumbent period was greater than the second (3 to 7 a.m.) consecutive recumbent period, suggesting that during the first sleeping period there was an augmented excretion to compensate for the preceding period of depressed excretion. Although renal functions are depressed during ambulation, there is a return to the control values during recumbency even though the blood pressure is reduced during hexamethonium therapy. Thus, this period during recumbency may also allow for necessary homeostatic balance or compensation to prevent retention of renal excretion products such as urea nitrogen.
SUMMARY AND CONCLUSIONS 1. Thirteen patients with hypertension have been observed during oral hexamethonium therapy. Observations were made during recumbency as well as during ambulation.
2. In the supine position, there was a reduction in blood pressure after hexamethonium without a reduction in renal plasma flow, glomerular filtration rate, or tubular excretory capacity. These observations indicate that the renal vessels in patients with hypertension are quite capable of dilating.
3. In the ambulatory state before hexamethonium, there was a depression of glomerular filtration, renal plasma flow, and TmPAH due to vasoconstriction. After hexamethonium therapy, the ambulatory state was accompanied by a further drop in blood pressure and a reduction in renal functions quite similar to those observed in the untreated patient but the changes were often more marked.
4. Ambulation after the administration of hexamethonium is accompanied by a decrease in the excretion of water, sodium, and potassium. This may be due to neurogenic impulses as suggested by the depression during ambulation alone without a drop in blood pressure.
5. Hexamethonium when used orally in the chronic treatment of hypertension appears to be acceptable since none of the changes described resulted in any significant alteration of their clinical status in terms of impaired excretion of nitrogenous substances or in the retention of sodium and water. Reactivity in the recumbent position seems to compensate for the depressed function during ambulation.
